Actively Recruiting
CRISAL Study:Cancer Risk In Secreting Adrenal Lesions
Led by University of Roma La Sapienza · Updated on 2024-08-30
300
Participants Needed
1
Research Sites
10 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of the present study is to report the cancer risk in secreting adrenal lesions. Secondary aims: to compare the incidence of cancer in secreting versus non-secreting adrenal lesions, in order to evaluate whether adrenal hormone activity can be considered an independent predictive indicator of malignancy; compare intraoperative and 30-day postoperative outcomes of patients undergoing adrenalectomy for secreting adrenal lesions versus non-secretoring lesions; regardless of the type of adrenal lesion, identify if there is one MIS adrenal approach that is superior to the others in terms of intra- and postoperative outcomes.
CONDITIONS
Official Title
CRISAL Study:Cancer Risk In Secreting Adrenal Lesions
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients undergoing elective adrenalectomy
- Patients aged �b�b�b18 years or older
- Acceptance of informed consent
You will not qualify if you...
- Patients undergoing emergency adrenalectomy
- Patients younger than 18 years
- Pregnant patients
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
General and Mininvasive Surgery Department, Pederzoli Hospital,
Peschiera del Garda, Verona, Italy., Italy
Actively Recruiting
Research Team
D
Diletta D Corallino
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here